Q & M Dental Group (Singapore) Ltd
SGX:QC7
Relative Value
The Relative Value of one QC7 stock under the Base Case scenario is 0.441 SGD. Compared to the current market price of 0.245 SGD, Q & M Dental Group (Singapore) Ltd is Undervalued by 44%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
QC7 Competitors Multiples
Q & M Dental Group (Singapore) Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
SG |
Q & M Dental Group (Singapore) Ltd
SGX:QC7
|
231.9m SGD | 1.3 | 20.1 | 7.9 | 14.2 | ||
US |
Cigna Corp
NYSE:CI
|
104.4B USD | 0.5 | 20.2 | 10.4 | 13.8 | ||
US |
C
|
Cigna Group
XMUN:CGN
|
96.9B EUR | 0.5 | 20 | 10.3 | 13.7 | |
US |
CVS Health Corp
NYSE:CVS
|
72.9B USD | 0.2 | 8.7 | 8 | 8 | ||
DE |
Fresenius Medical Care AG
XMUN:FME
|
22.7B EUR | 1.2 | 45.6 | 10.6 | 25.1 | ||
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
16.9B USD | 1.4 | 39 | 11.9 | 17.9 | ||
DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.8B EUR | 0.7 | -26.5 | 10.1 | 22.6 | |
US |
Quest Diagnostics Inc
NYSE:DGX
|
15.2B USD | 1.6 | 18.1 | 10.7 | 14.5 | ||
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.6B EUR | 0.6 | 23.3 | 6.9 | 16.4 | |
US |
DaVita Inc
NYSE:DVA
|
12.3B USD | 1 | 17.7 | 8.6 | 12.6 | ||
US |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 4.4 | -18.6 | -23.3 | -21.5 |